Abstract:BACKGROUND: We have developed a formulation of polycationic liposomes that has been shown to be non-toxic, highly stable in the bloodsteam, and very effective in liver gene transfer in mice (Gene Therapy 2003; 10:180–187). Extracellular superoxide dismutase (EC-SOD) inhibits the generation of superoxide anions in the interstitial space of tissues, and may play a role in minimizing oxidative stress in liver injury. The aim of the present study is to investigate whether our polycationic liposome-mediated human EC-SOD gene delivery will protect against lipopolysaccharide (LPS)-induced liver toxicity in D-galactosamine (GalN)-sensitized mice. METHODS: Polycationic liposomes were generated from polycationic lipid (PCL) and cholesterol (Chol). Lipoplexes were formed by complexing liposomes with control plasmid (pEGFP-C1) or EC-SOD plasmid (pEGFP-C1-ECSOD) before use. Mice were injected with thyroid hormone (T3, 4 mg/kg, s.c.) two days before lipoplexes were injected via the portal vein. One day following lipoplex injection, mice were treated with GalN (500 mg/kg, i.p.) plus LPS (25 mg/kg, i.p.). Serum alanine aminotransferase (ALT), SOD activity, liver histology, glutathione (GSH) content and lipid peroxidation were evaluated one day after GalN/LPS exposure. Human EC-SOD gene expression in mouse liver tissue was determined by quantitative RT-PCR two days after lipoplex injection. RESULTS: somes and the control lipoplexes were stable in their size for three months at 4°C. Injection of T3, PCL-Chol liposomes or control lipoplexes did not cause a significant change in serum ALT levels. Real time quantitative RT-PCR analysis showed that human EC-SOD mRNA levels in mouse liver tissue in EC-SOD lipoplex-injected group were 55-fold higher than saline, liposome or control lipoplex controls when mouse -actin was employed as a house-keeping control gene. Serum ALT levels in animals receiving portal vein injections of EC-SOD lipoplexes plus GalN/LPS exposure were much lower than in those receiving normal saline, liposomes alone, or control lipoplexes plus GalN/LPS exposure (62583 vs. 150865, 153194, 1880520 units/ml, p<0.01). Liver histology showed much less hepatocyte death in EC-SOD lipoplex-treated group than liposome- or control lipoplex-treated groups. Serum SOD activity in animals receiving injection of EC-SOD lipoplexes were higher than in those treated with liposomes only, or control lipoplexes (28.8 3.3 vs. 15.2 0.9, 17.4 3.4 units/ml, p<0.05). Liver GSH content in animals receiving EC-SOD lipoplex injection was preserved with less lipid peroxidation, as indicated by a lower level of malondialdehyde content. CONCLUSIONS: liposome-mediated EC-SOD gene delivery leads to the marked transgene expression, and attenuates acute liver injury due to reduced oxidative stress in GalN/LPS-exposed mice. To our knowledge, this is a first report which demonstrates that polycationic liposome-mediated EC-SOD gene delivery to the liver represents a potential therapy for hepatotoxin-induced liver injury.

Therapeutic Uptake of Oral Administrated Cu/Zn-Superoxide Dismutase Fused with Protein Transduction Domain

A Manganese-Superoxide Dismutase from Thermus Thermophilus HB27 Suppresses Inflammatory Responses and Alleviates Experimentally Induced Colitis

Liposome-mediated Extracellular Superoxide Dismutase Gene Delivery Protects Against Acute Liver Injury in Mice.

A Study on the Protective Effects of Protein Transduction Domain 4-Cu, Zn Superoxide Dismutase Fusion Protein Aganist Global Cerebral Ischemia/reperfusion Injury in Rats

Superoxide dismutase ameliorates oxidative stress and regulates liver transcriptomics to provide therapeutic benefits in hepatic inflammation

Inhibitory Effect on the Proliferation of Human Heptoma Induced by Cell-Permeable Manganese Superoxide Dismutase

A Study on the Time–Effect and Dose–Effect Relationships of Polysaccharide from Opuntia dillenii against Cadmium-Induced Liver Injury in Mice

Superoxide Dismutase Recombinantlactobacillus Fermentumameliorates Intestinal Oxidative Stress Through Inhibiting NF-κB Activation in a Trinitrobenzene Sulphonic Acid-Induced Colitis Mouse Model

Progress of Protein Transduction Domain-Superoxide Dismutase Fusion Protein in Cerebral Ischemia/reperfusion Injury

677. Polycationic Liposome-Mediated Extracellular Superoxide Dismutase Gene Delivery Leads to High Levels of the Transgene Expression and Prevents Acute Liver Injury in Mice

GST-TAT-SOD: Cell Permeable Bifunctional Antioxidant Enzyme-A Potential Selective Radioprotector

Lentivirus‐mediated Superoxide Dismutase1 Gene Delivery Protects Against Oxidative Stress‐induced Liver Injury in Mice

[Pharmacokinetics and Distribution of Superoxide Dismutase Liposomes in Rats].

28-Day Repeated Dose Oral Toxicity of Human Copper-Zinc Superoxide Dismutase from Recombinant Pichia Pastori in Rats.

Oral delivery of a highly stable superoxide dismutase as a skin aging inhibitor

Cholic acid modified N-(2-hydroxy)-propyl-3-trimethylammonium chitosan chloride for superoxide dismutase delivery.

Preparation and Characterization of pH-Sensitive Capsosomes for Oral Delivery of Therapeutic Proteins

The combined transduction of copper, zinc-superoxide dismutase and catalase mediated by cell-penetrating peptide, PEP-1, to protect myocardium from ischemia-reperfusion injury

Protein Transduction Domain4-Cu, Zn Superoxide Dismutase Fusion Protein Reduces Hypoxic Apoptosis in Human Astrocyte Cultures

[Effect of Superoxide Dismutase on Membrane Fluidity and Functions of Lymphocytes in Traumatized Mice].

Anti-proliferative Effects of Recombinant Iron Superoxide Dismutase on HepG2 Cells Via a Redox-Dependent PI3k/Akt Pathway.